FTC Approves Final Order Settling Charges that Johnson & Johnson’s Proposed Acquisition of Synthes, Inc. was Anticompetitive in Market for Treating Traumatic Wrist Injuries

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Johnson & Johnson’s proposed acquisition of Synthes, Inc. would have been anticompetitive in the market for surgical systems used to treat traumatic distal radius wrist fractures. The final FTC order resolving the charges requires Johnson & Johnson to sell its system for surgically treating serious wrist fractures.

The Commission vote approving the final order was 5-0. (FTC File No. 111-0160; Docket No. C-4363; the staff contact is Mark D. Seidman, Bureau of Competition, 202-326-3296; see press release dated June 11, 2012.)

The FTC’s Bureau of Competition works with the Bureau of Economics to investigate alleged anticompetitive business practices and, when appropriate, recommends that the Commission take law enforcement action. To inform the Bureau about particular business practices, call 202-326-3300, send an e-mail to [email protected], or write to the Office of Policy and Coordination, Bureau of Competition, Federal Trade Commission, 601 New Jersey Ave., Room 7117, Washington, DC 20580. To learn more about the Bureau of Competition, read Competition Counts. Like the FTC on Facebook, follow us on Twitter, and subscribe to press releases for the latest FTC news and resources.

(FYI 24.2012.wpd)

Leave a comment

Your email address will not be published. Required fields are marked *